BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21910644)

  • 1. Donor bone marrow-derived stem cells contribute to oral squamous cell carcinoma transformation in a recipient after hematopoietic stem cell transplantation.
    Hu YX; Luo Y; Tan YM; Shi JM; Sheng LX; Fu HR; Liu LZ; Xu YL; Wu KN; Xiao HW; Zhang LF; Yu XH; Cai Z; Huang H
    Stem Cells Dev; 2012 Jan; 21(2):177-80. PubMed ID: 21910644
    [No Abstract]   [Full Text] [Related]  

  • 2. Squamous cell carcinoma of the buccal mucosa in a young adult with history of allogeneic bone marrow transplantation for childhood acute leukemia.
    Tomihara K; Dehari H; Yamaguchi A; Abe M; Miyazaki A; Nakamori K; Hareyama M; Hiratsuka H
    Head Neck; 2009 Apr; 31(4):565-8. PubMed ID: 18972418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
    Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal squamous cell carcinoma developed 11 years after allogeneic bone marrow transplantation for acute lymphatic leukemia.
    Miyawaki Y; Imoto I; Tokairin Y; Kawada K; Nakajima Y; Nishikage T; Nagai K; Kajiwara M; Inazawa J; Kawano T
    Jpn J Clin Oncol; 2013 Jan; 43(1):69-73. PubMed ID: 23225908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation.
    Janin A; Murata H; Leboeuf C; Cayuela JM; Gluckman E; Legrès L; Desveaux A; Varna M; Ratajczak P; Soulier J; de Thé H; Bertheau P; Socié G
    Blood; 2009 Feb; 113(8):1834-40. PubMed ID: 19060240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up.
    Briones J; Urbano-Ispizua A; Orfao A; Marín P; Sierra J; Rovira M; Carreras E; Rozman C; Montserrat E
    Bone Marrow Transplant; 1998 Jan; 21(2):189-94. PubMed ID: 9489637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia.
    Marks DI; Alonso L; Radia R
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):995-1009. PubMed ID: 25459175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients.
    Lee JW; Kang HJ; Kim S; Lee SH; Yu KS; Kim NH; Jang MK; Kim H; Song SH; Park JD; Park KD; Shin HY; Jang IJ; Ahn HS
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):190-5. PubMed ID: 25255163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of BCR-ABL positive acute lymphoblastic leukemia in donor cells after allogeneic hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia.
    Athanasiadou A; Stamatopoulos K; Sakellari I; Zorbas I; Gaitatzi M; Fassas A; Anagnostopoulos A
    Bone Marrow Transplant; 2004 Jul; 34(2):189-91. PubMed ID: 15156167
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
    Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF
    N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cells of origin of squamous epithelium, dysplasia and cancer in the head and neck region after bone marrow transplantation.
    Kano Y; Ishii H; Konno M; Yamasaki M; Miyata H; Nishikawa S; Hamabe A; Ogawa H; Takahashi H; Ohta K; Hasegawa S; Tanaka K; Fukusumi T; Otsuka M; Kawamoto K; Haraguchi N; Fujimoto R; Isobe M; Tomita Y; Matsuura N; Takiguchi S; Mori M; Doki Y
    Int J Oncol; 2014 Feb; 44(2):443-50. PubMed ID: 24317739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Ma X; Wu D; Sun A; Qiu H; Fu Z; Wu X; Chen S; Mohty M
    Am J Hematol; 2010 Feb; 85(2):141-2. PubMed ID: 20029991
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study.
    Lazarevic VLj; Remberger M; Hägglund H; Hallböök H; Juliusson G; Kimby E; Malm C; Wahlin A; Omar H; Johansson JE
    Am J Hematol; 2011 Aug; 86(8):709-10. PubMed ID: 21761436
    [No Abstract]   [Full Text] [Related]  

  • 14. Squamous Cell Carcinoma of the Lip in a Patient With Graft-Versus-Host Disease.
    Kibbi N; Suozzi KC; Ko CJ; Leffell DJ
    Dermatol Surg; 2019 Jul; 45(7):1002-1005. PubMed ID: 31260417
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
    Hamad N; Shanavas M; Michelis FV; Uhm J; Gupta V; Seftel M; Kuruvilla J; Lipton JH; Messner HA; Kim DD
    Am J Hematol; 2015 May; 90(5):392-9. PubMed ID: 25615933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors.
    Konuma T; Kato S; Ooi J; Oiwa-Monna M; Tojo A; Takahashi S
    Ann Hematol; 2015 Feb; 94(2):289-96. PubMed ID: 25178518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of squamous cell carcinoma of the oral cavity in allogeneic hematopoietic stem cell transplant recipients.
    Reddy NM; Sullivan MA; Hahn TE; Battiwalla M; Smiley SL; McCarthy PL
    Bone Marrow Transplant; 2007 Nov; 40(9):907-9. PubMed ID: 17724441
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple and Recurrent Squamous Cell Carcinoma of the Oral Cavity After Graft-Versus-Host Disease.
    Weng X; Xing Y; Cheng B
    J Oral Maxillofac Surg; 2017 Sep; 75(9):1899-1905. PubMed ID: 28322198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple squamous cell carcinomas of the oral cavity in a young patient with graft-versus-host disease following allogenic bone marrow transplantation.
    Montebugnoli L; Gissi DB; Marchetti C; Foschini MP
    Int J Oral Maxillofac Surg; 2011 May; 40(5):556-8. PubMed ID: 21163622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extramedullary relapse of acute lymphoblastic leukemia in the breast after allogeneic stem cell transplantation and concomitant persistence of donor hematopoiesis.
    Manna A; Magli T
    Haematologica; 2001 Jul; 86(7):767-8. PubMed ID: 11454536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.